<<

. 53
( 61 .)



>>

Nuclear Security Administration, Of¬ce of Nonproliferation Policy (Febru-
ary 2002).
Salerno, Reynolds M., A Possible Approach to Biosecurity for the BMBL, Sandia
National Laboratories (April 12, 2004).
Salerno, Reynolds M., Biosecurity Methodology, Biosafety and Security Interna-
tional Program Review (March 31, 2004).
Salerno, Reynolds M., Defining Biosecurity in Theory and Practice, Sandia National
Laboratories (April 14, 2004).
Salerno, Reynolds M., Improving the Security of High-Consequence Microbial
Agents and Toxins, Sandia National Laboratories (March 14, 2002).
Salerno, Reynolds M., Secure Transfer of Select Agents, Presented at BWC Experts
Group Meeting (August 2003).
Salerno, Reynolds M., U.S. Laboratory Biosecurity Policy Paper, Sandia National
Laboratories (February 2002).
Shipping and Importing Biological Materials: Guidelines and Regulations, Mount
Sinai School of Medicine (2002).
312 BIBLIOGRAPHY

Shulman, Mark R., The Proliferation Security Initiative and the Evolution of the Law
on the Use of Force, 28 Houston Journal of International Law 3 (September
22, 2006).
Sprinkle, Robert H., The Biosecurity Trust, Bioscience, Vol. 53, No. 3 (March
2003).
Steele, Bill, Researchers Make Synthetic DNA ˜Barcodes™ to Tag Pathogens, Provid-
ing an Inexpensive, Off-the-Shelf Monitoring System eBiology News (June 13,
2005).
Steinbock, Daniel J., Data Matching, Data Mining, and Due Process, 40 GA. L. Rev.
1 (2005).
Sutton, Victoria, Dual Purpose Bioterrorism Investigations in Law Enforcement and
Public Health Protection: How to Make Them Work Consistent with the Rule of
Law, 6 Hous. J. Health L. & Pol™y 151 (Fall 2005).
Szyliowicz, Joseph S., International Transportation Security, Review of Policy
Research, Vol. 21, No. 3 (May 1, 2004).
Treadwell, Tracee A., et al., Epidemiologic Clues to Bioterrorism, Public Health
Reports, Vol. 118 (March“April 2003).
Tucker, Jonathan B., Biosecurity: Limiting Terrorist Access to Deadly Pathogens,
United States Institute of Peace (November 2003).
Tzannatos, E. S., A Decision Support System for the Promotion of Security in Shipping,
Disaster Prevention and Management: An International Journal, Vol. 12, No.
3 (2003).
UN Model Regulations on the Transport of Dangerous Goods, Committee of Experts
on the Transport of Dangerous Goods, United Nations Economic and Social
Council, 14th rev. ed., (2005).
Van de Voort, Martin, et al., “Seacurity,” Improving the Security of the Global Sea-
Container Shipping System, RAND Corporation (2004).
Watanabe, Myrna E., Bioterror Error, Hartford Courant (September 5,
2004).
Watson, Samuel, Joe Suyama, Stefanie Fiddner Junker, & Michael Allswede, Con-
necting the Dots: Characterizing Preparations for a Bio Attack, Unpublished
Paper “ Final Document (February 21, 2006).
Weaver, Jefferson Hane, Lessons in Multilateral Negotiations: Creating a Remote
Sensing Regime, 7 Temp. Int™l & Comp. L.J. 29 (Spring 1993).
White House, G-8 Action Plan on Proliferation, Federal Document Clearing House,
Inc. (June 9, 2004).
WHO Laboratory Biosafety Manual, Interim Guidelines 2nd ed. (2003).
Winner, Andrew C., The Proliferation Security Initiative: The New Face of Interdic-
tion, Washington Quarterly, Vol. 28, No. 2 (Spring 2005).
Wolfowitz, Paul, Paul Wolfowitz Announces a Presidential Directive to Strengthen
Biodefenses, FDCH Political Transcripts (April 28, 2004).
Yagupsky, Pablo, & Ellen Jo Baron, Laboratory Exposures to Brucellae and Implica-
tions for Bioterrorism; Perspective, Emerging Infectious Diseases, Vol. 11, No. 8
(August 1, 2005).
313
BIBLIOGRAPHY

Zanders, Jeal Pascal, A Verification and Transparency Concept for Technology Trans-
fers under the BWC, The Weapons of Mass Destruction Commission (December
17, 2004).


Chapter 6
2003 Biotech™s 2nd Best Year and 2004 Looks Better, Biotech Financial Reports
(February 2004).
A Survey of the Use of Biotechnology in U.S. Industry, U.S. Department of Commerce
(November 2003).
Abott, Frederick M., The WTO Medicines Decision: World Pharmaceutical Trade
and the Protection of Public Health, 99 A.J.I.L. 317 (2005).
Achievements in Public Health, 1900“1999 Impact of Vaccines Universally Recom-
mended for Children “ United States, 1990“1998, Centers for Disease Control
and Prevention, Morbidity and Mortality Weekly Report, Vol. 48, No. 12 (April
2, 1999).
Ad Hoc Group of the States Parties to the Convention on the Prohibition of the
Development, Production, and Stockpiling of Bacteriological (Biological) and
Toxin Weapons and on Their Destruction, Fulfilling the Objectives of the Biological
and Toxin Weapons Convention: Resolving the Issue of Trade and Exchange of
Technology, BWC/Ad Hoc Group/WP.424 (July 20, 2000).
Aggarwal, Raj, Technology and Globalization as Mutual Reinforcers in Business:
Reorienting Strategic Thinking for the New Millennium; Management Interna-
tional Review ( July 15, 1999).
Aginam, Obijiofor, Between Life and Profit: Global Governance and the Trilogy of
Human Rights, Public Health and Pharmaceutical Patents, 31 N.C.J. Int™l L. &
Com. Reg. 901 (Summer 2006).
Agreement on Trade-Related Aspects of Intellectual Property Rights, Marrakesh
Agreement Establishing the World Trade Organization (April 15, 1994).
AIDS Drugs; U.S. Offers to Help South Africa Obtain Affordable Medicines, Chicago
Tribune (August 2, 1999).
Aldhous, Peter, & Michael Reilly, Friend or Foe?; Efforts to Combat Killer Pathogens
with New Vaccines and Drugs Could Be Inadvertently Writing a Handbook for
Biowarfare, New Scientist (October 14, 2006).
Aldhous, Peter, The Accidental Terrorists; Too Many Biologists Remain Blind to
the Danger that They Could Be Aiding the Spread of Terrorism, New Scientist
( June 10, 2006).
An Introduction to Biological Weapons, their Prohibition, and the Relation-
ship to Biosafety, The Sunshine Project, Backgrounder Series, No. 10 (April
2002).
Andrawiss, Mariam, Plant-Made Pharmaceuticals; Biopharming Might Be as Easy
as Literally Growing Drugs on Trees, if It Wasn™t for the International Regulations,
Technical Challenges, and Safety Issues, Drug Discovery and Development
(March 1, 2006).
314 BIBLIOGRAPHY

Anex, Robert, Growing the Future, BioScience, Vol. 55, No. 10 (October 1, 2005).
Anthrax Vaccine Immunization Program (AVIP), Information Statement and
Acknowledgment, U.S. Department of Defense, available at http://www
.seafarers.org/members/Anthraxack.pdf.
Anthrax: Replacement for VaxGen Vaccine Likely ˜Years Away, American Health
Line (December 22, 2006).
Arnold, Wayne, Luring Top Stem Cell Researchers with Financing and Freedom,
New York Times (August 17, 2006).
Atlas, Ronald M., National Security and the Biological Research Community; Policy
Forum: Public Health, Science (October 25, 2002).
Attaran, Amir, How Do Patents and Economic Policies Affect Access to Essential
Medicines in Developing Countries?; Poverty, not Patent Policies, More Often
Inhibits Access to Essential Medicines in the Developing World, Health Affairs,
(May“June 2004).
Barker, Brent, Technology and the Quest for Sustainability, EPRI Journal ( June 22,
2000).
Behreandt, Dennis, Future Tech: 8 Amazing Scientific and Technological Advances
on the Horizon “ Made by Mixing Hefty Parts of Human Ingenuity with the Free-
dom to Employ It, New American, Vol. 22, No. 8 (April 17, 2006).
Bell, James John, Exploring the “Singularity,” Futurist, Vol. 37, No. 3 (May 1, 2003).
Bhutkar, Arjun, Synthetic Biology: Navigating the Challenges Ahead, 8 J. Biolaw &
Bus. 2 (2005).
Biotechnology for Sustainable Growth and Development, Meeting of the OECD
Committee for Scienti¬c and Technological Policy at Ministerial Level (Jan-
uary 29“30, 2004).
Biotechnology Industry Code of Conduct, AusBiotech: Australia™s Biotechnology
Organisation (March 2005).
Biotechnology Industry Statement of Ethical Principles, BIOTECanada: Canada™s
Voice for Biotechnology, available online at http://www.biotech.ca/
content.php?doc=19.
Biotechnology Research in an Age of Terrorism, Confronting the “Dual Use”
Dilemma, National Research Council of the National Academies (2003).
Black, Julia, Regulation as Facilitation: Negotiating the Genetic Revolution, 61 Mod.
L. Rev. 621 (1998).
Boerma, J. Ties; Holt, Elizabeth; & Black, Robert, Measurement of Biomarkers in
Surveys in Developing Countries: Opportunities and Problems, Population and
Development Review, Vol. 27, No. 2 ( June 1, 2001).
Boyle, Francis A., Biowarfare and Terrorism, Clarity Press, Inc., (2005).
Braach-Maksvytis, Vijoleta, & Biesenbach, Reinie, The Global Research Alliance:
A Knowledge Pool for Global Good, UN Chronicle, Vol. 42, No. 1 (March 1,
2005).
Brainard, Jeffrey, Scientists Question Buildup in Biodefense Spending, Chronicle
of Higher Education (March 25, 2005).
315
BIBLIOGRAPHY

Brickner, Philip W. et al., The Application of Ultraviolet Germicidal Irradiation to
Control Transmission of Airborne Disease: Bioterrorism Countermeasure; Practice
Articles, Public Health Reports, Vol. 118, No. 2 (March 1, 2003).
Brignati, Michael J., Access to the Safe Harbor: Bioterrorism, Influenza, and the
Supreme Court™s Interpretation of the Research Exemption from Patent Infringe-
ment, 13 J. Intell. Prop. L. 375 (Spring 2006).
Broad, William J., & Judith Miller, A Nation Challenged: The Investigation; U.S.
Recently Produced Anthrax in a Highly Lethal Powder Form, New York Times
(December 13, 2001).
Bruntland, Gro Harlem, Global Health and International Security; Global Insights,
Global Governance (October 1, 2003).
Buckland, Barry C., The Process Development Challenge for a New Vaccine, Nature
Medicine, Vol. 11 (April 2005).
Campaign for the Peaceful Development of the Biological Sciences, Council for
Responsible Genetics, ( June 30, 2004).
Cardiac Deaths After a Mass Smallpox Vaccination Campaign “ New York City,
1947, Centers for Disease Control and Prevention, Morbidity and Mortality
Weekly Report, Vol. 52 (October 3, 2003).
Carr, Kathleen, et al., Implementation of Biosurety Systems in a Department of
Defense Medical Research Laboratory, Biosecurity and Bioterrorism: Biode-
fense Strategy, Practice, and Science, Vol. 2, No. 1 (2004).
Cello, Jeronimo, et al., Chemical Synthesis of Poliovirus cDNA: Generation of Infec-
tious Virus in the Absence of Natural Template, Sciencexpress ( July 11, 2002).
Chiarello, Kaylynn, New Vaccine Technologies Carry and Deliver, Pharmaceutical
Technology, Vol. 29, No. 5 (May 1, 2005).
Clarke, Victoria, Defense Department Regular Briefing, Federal News Service
(September 4, 2001).
Code of Conduct for Life Science Professionals, University of Southern California
Global Business Initiative, http://www.globalbiobusiness.org/bioethics.html.
Code of Ethics, American Society for Microbiology (2005).
Collard-Wexler, Simon, Comparative Review of Biosecurity-Related Legislation,
Center for Nonproliferation Studies, Monterey Institute of International
Studies (September 2002).
Commission Directive 2003/63/EC on the Community Code Relating to Medicinal
Products for Human Use (June 25, 2003).
Committee on Advances in Technology and the Prevention of Their Application
to Next Generation Biowarfare Threats, Globalization, Biosecurity, and The
Future of The Life Science, The National Academies Press (2006).
Conference of the Parties to the Convention on Biological Diversity Serving as
the Meeting of the Parties to the Cartagena Protocol on Biosafety, UNEP/CBD/
BS/COP-MOP/1/8. 23“27 (February 2004).
Conference on Ethical Implications of Scientific Research on Bioweapons and
Prevention of Bioterrorism, European Commission, DG Research Directorate
316 BIBLIOGRAPHY

E: Biotechnology, Agriculture and Food Research (February 3“4,
2004).
Cookson, Clive, Eastern Rebirth of the Life Sciences RESEARCH AND DEVELOP-
MENT IN ASIA, Financial Times ( June 10, 2005).
Cox, George, et al., Driving Innovation Forward: A Round-Table Discussion, New
Statesman (January 16, 2006).
Declaration on Science and the Use of Scientific Knowledge, UNESCO, World Con-
ference on Science ( July 1, 1999).
Declaration on the TRIPS Agreement and Public Health, World Trade Organiza-
tion, Ministerial Conference, 4th Session, WT/MIN(01)/DEC/W/2 (November
14, 2001).
Definitions and Regulations Involved in the Classified-Sensitive Information-
Unclassified Debate, Association of American Universities (March 3, 2003).
Derek, Ellison, Accelerating European Biomanufacturing, Pharmaceutical Tech-
nology Europe, Vol. 16, No. 9 (September 1, 2004).
Donohue, Laura K., Censoring Science Won™t Make Us any Safer, Washington Post
( June 26, 2005).
Draft Recommendations for a Code of Conduct for Biodefense Programs, Federation
of American Scientists (November 2002).
Dreyfuss, Barbara, Patents Pending, National Legislative Association on Pre-
scription Drug Prices (February 23, 2005).
Dyer, Geoff, et al., U.S. Climbs Down Over Brazil™s Patent Law, Financial Times
(London) ( June 26, 2001).
Elhefnawy, Nader, Societal Complexity and Diminishing Returns in Security, Inter-
national Security (Summer 2004).
Ensirenk, Martin, Entering the Twilight Zone of What Material to Censor, Science
(November 22, 2002).
Ethical Aspects of Clinical Research in Developing Countries, Opinion of the Euro-
pean Group on Ethics in Science and New Technologies to the European Com-
mission, No. 17 (February 4, 2003).
EU Draft Proposal for a Compromise Solution, Consumer Project on Technology
(2003).
European Commission “ Science and Society, Globalization and New Epidemics:
Ethics, Security, and Policy Making, Bioethical Implications of Globalization Pro-
cesses (May 2006).
Evans, G., Vaccine Injury Compensation Programs Worldwide, HRSA Advisory Com-
mission on Childhood Vaccines Meeting and Conference Call Minutes (March 9,
2006).
Falcon, Walter P., & Rosamond L. Naylor, Rethinking Food Security for the Twenty-
first Century, American Journal of Agricultural Economics, Vol. 87, No. 5
(December 1, 2005).
Farmer, Paul, & Nicole Gastineau Campos, New Malaise: Bioethics and Human
Rights in the Global Era, Journal of Law, Medicine & Ethics (Summer 2004).
317
BIBLIOGRAPHY

Fauci, Anthony S., Bioterrorism: Defining a Research Agenda, 57 Food Drug L.J. 413
(2002).
Ferrone, Jason D., Compulsory Licensing During Public Health Crises: Bioterrorism™s
Mark on Global Pharmaceutical Patent Protection, 26 Suffolk Transnat™l L. Rev.
385 (Summer 2003).
Field, Robert I., et al., Toward a Policy Agenda on Medical Research Funding: Results
of a Symposium; Greater Cooperation among Government, Industry, and Foun-
dations is Vital, Health Affairs (May“June 2003).
Fonda, Darren, Inside the Spore Wars, Time (January 9, 2006).
Fox, John, Legislators Propose Measure to Speed Up Biodefense Program, Global
Security Newswire (February 22, 2007).
Frazier, Marvin E. et al., Realizing the Potential of the Genome Revolution: The
Genomes to Life Program, Science (April 11, 2003).
Fresco, Louise O., A New Social Contract on Biotechnology, FAO (2003).
Fukuda-Parr, Sakiko, Millennium Development Goals: Why They Matter, Global
Governance, (October 1, 2004).
Future Visions; How Will Genetics Change Our Lives? Time Magazine (February 17,
2003).
Gaudioso, Jennifer, & Reynolds M. Salerno, BioSecurity and Research: Minimizing
Adverse Impacts, Science, Vol. 304, No. 5671 (April 30, 2004).
Geissler, Erhard, & John P Woodall (eds.), Control of Dual-Threat Agents: The Vac-
.

<<

. 53
( 61 .)



>>